Cost-utility analysis of second-line axicabtagene ciloleucel versus standard of care in Japan based on the ZUMA-7 trial
Article in Future Oncology (June 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Future Oncology (June 2024)
Article in Oncology and Therapy (February 2024)
Article in Blood Cancer Journal (January 2024)